Curative Biotechnology, Inc. (CUBT)
USD 0.01
(0.04%)
USD 0.01
(0.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -97.51 Thousand USD | -1125.68% |
| 2022 | -7956.00 USD | -17.97% |
| 2021 | -6744.00 USD | -27.22% |
| 2020 | -5301.00 USD | 0.0% |
| 2019 | -5301.00 USD | 0.0% |
| 2018 | -5301.00 USD | 0.0% |
| 2017 | -5301.00 USD | -149.62% |
| 2016 | 10.68 Thousand USD | -87.59% |
| 2015 | 86.06 Thousand USD | -14.12% |
| 2014 | 100.21 Thousand USD | -67.47% |
| 2013 | 308.06 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -26.42 Thousand USD | 71.13% |
| 2024 Q2 | -21.92 Thousand USD | 17.03% |
| 2023 Q1 | -1989.00 USD | 0.0% |
| 2023 FY | -97.51 Thousand USD | -1125.68% |
| 2023 Q4 | -91.54 Thousand USD | -4502.71% |
| 2023 Q3 | -1989.00 USD | 0.0% |
| 2023 Q2 | -1989.00 USD | 0.0% |
| 2022 FY | -7956.00 USD | -17.97% |
| 2022 Q4 | -1989.00 USD | -0.05% |
| 2022 Q3 | -1988.00 USD | 0.05% |
| 2022 Q2 | -1989.00 USD | 0.0% |
| 2022 Q1 | -1989.00 USD | 0.0% |
| 2021 FY | -6744.00 USD | -27.22% |
| 2021 Q4 | -1989.00 USD | 0.05% |
| 2021 Q2 | -2004.00 USD | -163.68% |
| 2021 Q1 | -760.00 USD | 0.0% |
| 2021 Q3 | -1990.00 USD | 0.7% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | -5301.00 USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 FY | -5301.00 USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | -5301.00 USD | 0.0% |
| 2017 FY | -5301.00 USD | -149.62% |
| 2016 FY | 10.68 Thousand USD | -87.59% |
| 2015 FY | 86.06 Thousand USD | -14.12% |
| 2014 FY | 100.21 Thousand USD | -67.47% |
| 2014 Q1 | 14.71 Thousand USD | -77.6% |
| 2013 Q1 | 79.22 Thousand USD | 0.0% |
| 2013 Q4 | 65.67 Thousand USD | 0.0% |
| 2013 FY | 308.06 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.833% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 69.48% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -102.066% |
| Qrons Inc. | - USD | Infinity% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 21.518% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.082% |
| Adynxx, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.622% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 169.406% |
| Arch Therapeutics, Inc. | -2439.00 USD | -3898.155% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.65% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 3243.617% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.996% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 248.361% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -185.549% |
| Mesoblast Limited | -35.16 Million USD | 99.723% |
| Marizyme, Inc. | 457.7 Thousand USD | 121.305% |
| Genus plc | 178.7 Million USD | 100.055% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.044% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 256.711% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 123.775% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -786.5% |
| ContraFect Corporation | -154 Thousand USD | 36.679% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -95.03% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 227.037% |
| IMV Inc. | -962.29 Thousand USD | 89.866% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 74.835% |
| MultiCell Technologies, Inc. | 49.32 USD | 197818.978% |
| ONE Bio Corp. | 20.12 Million USD | 100.485% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.242% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 299.417% |
| Q BioMed Inc. | -8988.00 USD | -984.947% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.345% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -532.229% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.22% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 91.458% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 239.307% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -1869.204% |
| GB Sciences, Inc. | -624.00 USD | -15527.404% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -13.353% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.001% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -46782.212% |
| Enzolytics Inc. | 30.7 Thousand USD | 417.556% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 120.213% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.009% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 81.047% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 115.795% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.024% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -1001.118% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -16.298% |
| Kadimastem Ltd | -630.13 Thousand USD | 84.525% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 109.87% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 101.015% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.632% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -723.954% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 155.231% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 155.231% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 107.185% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -236.259% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 121.668% |
| SYBLEU INC | 11.69 Thousand USD | 933.747% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 102.116% |
| Bioxytran, Inc. | -8285.00 USD | -1077.007% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 73.857% |
| Neutra Corp. | 14.33 Thousand USD | 780.258% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -18.921% |
| PureTech Health plc | -1.6 Million USD | 93.917% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 90.261% |
| IXICO plc | 3.27 Million USD | 102.982% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 85.949% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 94.555% |
| CSL Limited | 7.7 Billion USD | 100.001% |
| Cellectis S.A. | 18 Thousand USD | 641.75% |